Article Sidebar
Published:
Aug 10, 2022Keywords:
Article Details
Submission of a manuscript to this journal is a representation that the manuscript has not been published previously and is not under consideration for publication elsewhere.
All authors named in each manuscript would be required to sign a form (to be supplied by the Editor) so that they may retain their copyright in the article but to assign to us (the Publishers) and its licensees in perpetuity, in all forms, formats and media (whether known or created in the future) to (i) publish, reproduce, distribute, display and store the contribution, (ii) translate the contribution into other languages, create adaptations, reprints, include within collections and create summaries, extracts and/or abstracts of the contribution, (iii) create any other derivative works(s) based on the contribution, (iv) to exploit all subsidiary rights in the contribution, (v) the inclusion of electronic links from the contribution to third party material where-ever it may be located, and (vi) license any thrid party to do any or all of the above.
Main Article Content
Efficacy of combined nebulized aerosol inhalation and pulmicort respules in the treatment of emergency pediatric laryngitis, and its effect on adverse reactions
Abstract
Purpose: To determine the efficacy of combined use of nebulized epinephrine inhalation and pulmicort
respules in the treatment of emergency pediatric laryngitis and, its impact on the incidence of adverse reactions.
Methods: A total of 100 cases of pediatric laryngitis admitted in The People’s Hospital of Zhangqiu District between December 2018 and December 2020 were randomly assigned (1:1) to receive either pulmicort respules (control group) or pulmicort respules plus nebulized epinephrine inhalation treatment (study group). Outcome measures included level of effectiveness and adverse reactions.
Results: Pulmicort respules plus nebulized epinephrine inhalation treatment was associated with shorter remission time for dyspnea, wheeze, croup, and hoarseness versus pulmicort respules. The combination treatment produced higher total effectiveness of 96 % than pulmicort respules with total effectiveness of 82 % (p < 0.05). After treatment, both groups had decreased serum levels of interleukin-8 (IL-8), IL-6, C-reactive protein (CRP), and tumor necrosis factor (TNF)-α, with markedly lower levels in the group given nebulized epinephrine inhalation in combination with pulmicort respules (p < 0.05). Compared with patients given pulmicort respules only, those given combination treatments had a significantly shorter hospitalization time and a lower incidence of adverse reactions (4 vs 8 %; p < 0.05).
Conclusion: Nebulized epinephrine inhalation in combination with pulmicort respules has high safety in the treatment of emergency pediatric laryngitis, and it significantly reduces clinical symptoms, inflammatory response, and hospital stay. However, further clinical trials are required prior to its use in clinical practice.
